More Information on Access to Medicine

Comments to the European Commission on Customs Regulation 1383/2003

May 25, 2010

Recent customs actions in the European Union have stopped lifesaving generic medicines in transit to developing countries. To help protect global access to safe and effective medicines, Public Citizen recommends limiting ex officio customs actions to cases of willful trademark counterfeiting on a commercial scale. Public Citizen's comments also propose more effective measures to protect consumers from falsified and other unsafe medicines.
Read comments as a pdf.

Back to Medicine Quality and Anti-Counterfeit Policy Page

Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.